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ABSTRACT 
Labeling of large RNAs with reporting entities, e.g. fluorophores, has significant impact on 
RNA studies in vitro and in vivo. Here we describe a minimally invasive RNA labeling 
method featuring nucleotide- and position-selectivity, which solves the long-standing 
challenge of how to achieve accurate site-specific labeling of large RNAs with a least 
possible influence on folding and/or function. We use a custom-designed reactive DNA 
strand to hybridize to the RNA and transfer the alkyne group onto the targeted adenine or 
cytosine. Simultaneously, the 3'-terminus of RNA is converted to a di-aldehyde moiety under 
the experimental condition applied. The incorporated functionalities at the internal and the 3’-
terminal sites can then be conjugated with reporting entities via bioorthogonal chemistry. 
This method is particularly valuable for, but not limited to, single-molecule fluorescence 
applications. We demonstrate the method on an RNA construct of 275 nucleotides, the btuB 
riboswitch of Escherichia coli. 
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Labeling of long RNAs remains challenging due to the lack of a universally applicable 
method that allows the conjugation of reporting entities in an orthogonal, yet site-specific 
manner. Existing methods suffer from either the exponentially reduced labeling efficiency 
with increasing RNA size or the disruption of the correct fold and thus function of the RNA 
[111]. Here, we describe a post-transcriptional labeling method [12] that employs a 
customized DNA oligonucleotide as reactive strand (dRS) to transfer an alkyne group on any 
adenine or cytosine residue within an RNA strand of arbitrary length [13, 14]. To increase the 
yield of this chemical reaction, we make use of DNA oligonucleotides as helper sequences 
(dHSs) preventing secondary structure formation and increasing the accessibility of the 
target site [15]. In this one-pot reaction the 3'-terminal ribose ring is concomitantly opened to 
a di-aldehyde moiety [16] leading to the functionalized RNA with an internal alkyne and a 
reactive 3’-terminal end, which allows for bioorthogonal chemistry without cross-reactivity. 
We use the two carbocyanine dyes Cy3-hydrazide for coupling to the 3’-terminal di-aldehyde 
moiety and Cy5-azide for reaction with the internal-alkyne unit, to obtain a dual-color labeled 
btuB riboswitch RNA of 275 nt [17, 18]. The labeled construct is used for single-molecule 
fluorescence resonance energy transfer (smFRET) studies [12] as an example but the 
presented method can be adapted for any technique that requires labelling of RNAs without 
restriction in size and fold. 
2. Materials 
If not stated otherwise, chemicals were obtained in highest commercially available grades 
from Sigma-Aldrich/Merck (Buchs, Switzerland) and used without further purification. All 
buffers were prepared with ultrapure water (Thermo Fisher Scientific water purification 
systems) and filtered before use. Solutions and chemicals are kept at room temperature 
unless indicated otherwise. DNA oligonulceotides were purchased from IBA (Göttingen, 
Germany). Carbocyanine fluorophores were purchased from Lumiprobe (Hannover, Germany) 
and always protected from light. 
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2.1 Organic solvents and agents  
1. DMSO (purum). 
2. DMF (purum). 
3. Ethanol (EtOH, 100%). 
4. Acetone (purum). 
5. Reactive group precursor (Fig. 1a), synthesized as described in [14]. 
6. N-Hydroxysuccinimide (NHS). 
7. N, N'-Dicyclohexylcarbodiimide (DCC). 
8. 2,2'-Pyridine disulfide (PDS): 1.6 M in DMSO. 
9. 4-Dimethylaminopyridine (DMAP): 1.2 M in DMSO. 
10. Triphenylphosphine (PPh3): 1.2 M in DMF. 
11. Ethylene diamine (purum). 
12. Formamide (purum). 
13. Lithium perchlorate (LiClO4): 2% (w/v) in acetone. 
14. Ethylenediaminetetraacetic acid (EDTA). 
15. Xylene cyanole. 
16. Bromophenol blue. 
17. Tris(benzyltriazolylmethyl)amine (TBTA). 
18. Copper(II) sulfate (CuSO4). 
19. Acrylamide/bisacrylamide solution (30%) 
20. Urea 
2.2 Buffers and solutions 
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1. Potassium phosphate buffer: 100 mM, pH 7.5.  
2. Sodium acetate (NaOAc) buffer (50 ×, 1 ×): 1.0 M, 20 mM in water, pH 5.5. 
3. Triethylammonium acetate (TEAA) buffer: 0.5 M, pH 7.0. 
4. Soaking buffer: 10 mM MOPS, 1.0 mM EDTA and 250 mM NaCl, pH 6.0. 
5. Folding buffer (5 ×): 330 mM HEPES, 200 mM Tris-HCl and 250 mM KCl, pH 7.5. 
6. Running buffer (1 ×): 66 mM HEPES, 34 mM Tris-HCl and 3.0 mM MgOAc, pH 7.5. 
7. Tris-borate-EDTA (TBE, 10 ×) buffer, Thermo Fisher Scientific.  
8. Formamide loading buffer (FLB): 82% (v/v) formamide, 10 mM EDTA, 0.16% (w/v) xylene 
cyanole and 0.16 (w/v) bromophenol blue. 
9. Cetyltrimethylammonium bromide (CTAB): 8% (w/v) in water. 
10. Sodium chloride (NaCl): 3.0 M in water. 
11. Sodium periodate (NaIO4): 20 mM, in NaOAc buffer (1 ×). 
12. Ethylene glycol: 15 mM, in NaOAc buffer (1 ×) 
13. Ascorbic acid: 5.0 mM in water. 
14. MgCl2: 30 mM in water. 
15. KCl: 1.0 M in water 
16. Cu-TBTA solution: 10 mM CuSO4 and 10 mM TBTA in 55% (v/v) DMSO/water. 
2.3 Deoxyribonucleotide triphosphate (dNTP), DNA oligonucleotides and RNA 
1. dNTPmix: 10 mM, New England Biolabs 
2. Guide-DNA (Fig. 1b) solution: 4.0 mM in water. 
3. Helper sequence (dHS) solution: 100 µM in water. 
4. 5’-32P-labeled DNA primer (32P-primer): 1.0 µM in water, prepared as described in [19]. 32P-
γ-ATP was purchased from PerkinElmer (Schwerzenbach, Switzerland). 
5. Biotin-tagged DNA oligonucleotides: 1 μM in water. 
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6. The modified btuB riboswitch RNA was designed for smFRET immobilization studies 
according to the literature [12]. In vitro RNA transcription was performed with homemade T7 
polymerase [20]. 
2.4 Fluorophores 
1. Cyanine3 hydrazide (Cy3-hydrazide): 10 mM in DMSO.  
2. Sulfo-Cyanine5 azide (Cy5-azide): 10 mM in DMSO. 
2.5 Kits and columns 
1. AMV reverse transcriptase kit: enzyme in glycerol (2 U/µL), enzyme buffer (4 ×) and RNase 
inhibitor (40 U/µL), New England Biolabs. 
2. SuperScript III reverse transcriptase kit: enzyme in glycerol (20 U/µL), enzyme buffer (4 ×) 
Dithiothreitol (DTT, 0.1 M) and RNase inhibitor (40 U/µL), Thermo Fisher Scientific 
3. NAP-5 desalting column, GE Healthcare. 
2.6 Poly acrylamide gel electrophoreses (PAGE) gel 
1. 5%, 10% and 18% denaturing PAGE: TBE buffer (1 ×), 7 M urea and 5%, 10% and 18% 
(w/v) acrylamide/bisacrylamide. 
2. 6% native PAGE: running buffer 3 mM MgOAc, 66 mM HEPES and 34 mM Tris-HCl, pH 
7.5, 6% (w/v) acrylamide/bisacrylamide. 
3. Methods 
3.1 Preparation of the reactive group, Solution I 
1. Weigh 3.1 mg of reactive group precursor (Fig. 1a see Note 1) and 1.5 mg of NHS in a 
1.5 mL tube and dissolve it in 80 μL DMF. Weigh 2.7 mg of DCC in another 1.5 mL tube and 
dissolve it in 20 μL DMF. Mix both solutions together and incubate the mixture at room 
temperature and 500 rpm overnight (see Note 2). 
2. Centrifuge the mixture at 4 oC and 16.1  103 rfc for 10 min. Collect the supernatant which 
contains the activated reactive group in a clean 1.5 mL tube and keep it on ice (see Note 3). 
Referred to as Solution I. 
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3.2 Preparation of the ethylene diamine-modified guide-DNA, Solution II 
1. Prepare 25 μL of the guide-DNA (see Note 4) solution in a 1.5 mL tube and add 6.0 μL of 
CTAB solution (see Note 5). Mix gently and incubate at room temperature and 500 rpm for 
30 min. Centrifuge at room temperature and 16.1  103 rfc for 30 min. Remove and discard 
the supernatant and dry the precipitate in vacuum for 10 min. Dissolve the remaining pellet 
in 50 μL DMSO. 
2. Mix 50 μL of PDS (see Note 6), 50 μL of DMAP and 50 μL of PPh3 solution (see Note 7). 
Combine the mixture in the tube with the 50 μL DMSO solution containing the guide-DNA 
from the last step. Mix well and incubate the mixture at room temperature and 500 rpm for 
30 min. Add 8.0 μL of ethylene diamine and incubate for 30 min. Add 1.0 mL of LiClO4 
acetone solution. Mix thoroughly and store at -80 oC for 3 h. 
3. Take the tube from -80 oC and centrifuge at 4 oC an d 16.1  103 rfc for 30 min. Wash the 
pellet with acetone. Centrifuge at 4 oC and 16.1  103 rfc for 5 min. Remove the supernatant 
carefully with a pipette. Dry the pellet in vacuum at room temperature for 10 min. Dissolve 
the dried pellet in 10 μL of potassium phosphate buffer. Referred to as Solution II. 
3.3 Preparation of the reactive strand (dRS), Solution III 
1. Mix 2.0 μL of Solution I with 10.0 μL of Solution II in a 1.5 mL tube. Mix gently. Incubate 
the mixture at room temperature and 500 rpm for 1 h. Add 1.0 μL of NaCl solution and 1.0 
mL of ethanol. Mix the solution well and store it at -80 oC for 3 h. 
2. Take the tube from -80 oC and centrifuge at 4 oC and 16.1  103 rfc for 30 min. Remove 
the supernatant and dry the precipitate in vacuum at room temperature for 10 min. Dissolve 
the dried pellet in 25 µL of NaOAc buffer (50 ×). Place the solution on ice (see Note 8). 
Referred to as Solution III. 
3.4 dRS-hybridized RNA, Solution IV. 
1. Prepare 80 μL of the btuB riboswitch sample (~36.0 µM) in NaOAc buffer (1 ×) and add 30 
μL of dHS solutions (Fig. 2, see Note 9). Mix gently. Heat the mixture at 70 °C for 5 min and 
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cool down slowly to room temperature for about 30 min without agitation to allow for 
hybridization of the dHS. Centrifuge at low speed shortly to recollect any condensated 
solvent from the lid. 
2. Add 25µL of Solution III. Mix gently. Incubate the solution at room temperature for 10 min 
without agitation to allow for hybridization of the dRS and place it on ice before continuing to 
the next step (see Note 8). Referred to as Solution IV. 
3.5 Crude functionalized RNA, Solution V. 
1. Add 15 µL of NaIO4 solution to Solution IV of the previous step. Incubate the mixture at 
room temperature and 500 rpm for 90 min (see Note 10). Add 30 µL of ethylene glycol 
solution and mix well. Incubate at room temperature and 500 rpm overnight (see Note 11). 
Stop the reaction by applying the solution to a NAP-5 column and elute the sample with 
water. 
2. Lyophilize the eluted sample solution overnight, giving white spongy precipitate. Spin 
down the precipitate to the bottom of the tube. Add a minimal volume of water or potassium 
phosphate buffer to dissolve the spongy precipitate (see Note 12). Store the product at -20 
oC or keep it on ice if the purification will be carried out the same day. Referred to as 
Solution V. 
3.6 Purification of functionalized RNA, Solution VI.  
1. Add one volume equivalent of FLB to Solution V. Mix gently. Load the mixture on a 5% 
denaturing PAGE (see Note 13 and 14). Run the PAGE at 10-20 W at 4 °C for about 1.5 h 
or before the lower marker-dye migrates to the bottom edge of the gel. Check carefully not to 
lose RNA. 
2. Use a spatula to pry the glass plates and move the gel body to a plastic wrap. Place the 
gel body under a UV lamp to visualize (R)NA bands. Cut out the bands that correspond to 
the correct size (see Note 15). Collect the gel pieces in clean 1.5 mL tubes. To each tube, 
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add 800 µL soaking buffer. Fix the tubes on a low-speed rotary at 4 °C for 2.5 h and gently 
mix every 20 min. 
3. Centrifuge the tubes containing the soaked mixture at 4 oC and 16.1  103 rfc for 30 min. 
Collect the supernatant to new 1.5 mL tubes (see Note 16) keeping the volume of the 
supernatant in each tube below 350 µL. Add three volume equivalents ice cold ethanol to 
each tube. Mix well and store it at -80 oC overnight. 
4. Take the tubes from -80°C and centrifuge the precipitated sample at 4 oC and 16.1  103 
rfc for 30 min. Remove the supernatant and dry the precipitate in vacuum at room 
temperature for 5 min. Dissolve the pellet in water or buffer as needed. Referred to as 
Solution VI (see Note 17). 
3.7 3’-terminal labeled RNA, Solution VII  
1. Prepare 25 µL of Solution VI (RNA ~25 µM) in TEAA buffer in a 1.5 mL tube. Mix with 5.0 
µL formamide and 5.0 µL DMSO. Flush the solution with argon for 1 min (see Note 18). Add 
2.0 µL of argon-flushed Cy3-hydrazide solution (see Note 19) [16]. Mix gently and incubate 
the solution in the dark at room temperature and 500 rpm overnight. 
2. To stop the reaction add 1.0 mL of ethanol to the tube. Mix gently and store at -80 °C for 3 
h. Take the tube from -80 °C and centrifuge at 4 °C and 16.1  103 rfc for 30 min. Remove 
the supernatant and wash with 200 µL ice cold ethanol. Centrifuge again for 10 min (see 
Note 20) and dry the pellet under vacuum at room temperature for 5 min. Dissolve the pellet 
in 25 µL TEAA buffer. Referred to as Solution VII (see Note 21). 
3.8 Dual-color labeled RNA, Solution VIII 
1. Mix 25 µL of Solution VII with 10 µL formamide, 55 µL DMSO, 2.0 µL Cy5-azide solution 
(see Note 21), and 10 µL ascorbic acid solution (see Note 22). Flush the mixture with argon 
for 1 min (see Note 18) and add 10 µL Cu-TBTA solution. Flush the mixture with argon for 1 
min and incubate it in the dark at 25 °C and 500 rpm overnight. 
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2. To stop the reaction add 1.0 mL of ethanol to the tube. Mix gently and store the mixture at 
-80 °C for 3 h. Take the tube from -80 °C and centrifuge at 4 °C and 16.1  103 rfc for 30 
min. Remove the supernatant, wash with 200 µL ice cold ethanol and centrifuge again for 10 
min (see Note 20). Dry the pellet in vacuum at room temperature for 5 min. Dissolve the 
pellet in water and apply it to a NAP-5 desalting column (see Note 23). Elute with water and 
lyophilize overnight (see Note 12). 
3. Purify the lyophilized product in a 5% denaturing PAGE (see Note 24) following the same 
protocol as in 3.6 (see Note 25). Dissolve the recovered RNA in 20 µL water or potassium 
phosphate buffer. Referred to as Solution VIII.  
Characterize the dual-color labeled btuB riboswitch in comparison with the non-labeled one 
in a 10% denaturing PAGE (Fig. 4, see Note 26). 
3.9 Reverse transcription stop assay 
For a labeling site at the base-paired region, A213 (Fig. 5a, see Note 27) 
1. Mix 2.0 µL of Solution VIII (RNA ~ 1.0 µM, see Note 28) with 2.0 µL of the 32P-labeled 
primer solution (see Note 29) and 4.0 µL of dNTPmix. Mix gently. Heat at 70 °C for 5 min and 
cool on ice for 1 min.  
2. Add 1.0 µL of RNAse inhibitor and 2.0 µL of AMV reverse transcriptase (RT) buffer. Mix 
gently and incubate at 42 °C for 1 min. 
3. Add 1.0 µL of AMV RT and mix gently. Incubate the sample at 42 °C for 1 h without 
agitation. 
For a labeling site at the internal loop, A35 (Fig. 5b, see Note 27).  
1. Mix 1.0 µL of Solution VIII (RNA ~ 1.0 µM, see Note 28) with 1.0 µL of the 32P-labeled 
primer (see Note 29) and 4.0 µL of dNTPmix. Mix gently. Heat at 70 °C for 5 min. Place on 
ice for 5 min. 
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2. Add 1.0 µL of Rnase inhibitor, 1.0 µL of DTT and 3.0 µL of SuperScript III RT buffer. Mix 
gently and incubate at 52 °C for 1 min. 
3. Add 1.0 µL of SuperScript III RT and mix gently. Incubate the sample at 52 °C for 1 h 
without agitation. 
4. For both cases, stop the reactions by heating the sample to 90 °C and incubate for 5 min. 
Then, add one equivalent volume of FLB to the sample. Load the sample directly on a 18% 
denaturing PAGE gel. After drying, the gel was exposed to a phosphor imaging screen 
overnight and scanned the following day (see Fig. 5 and Note 30). 
3.10 Sample annealing and purification for smFRET measurements 
1. Mix 1.0 µL of Solution VIII (RNA ~ 1.0 µM) with 1.0 µL biotin-DNA oligonucleotides (see 
Note 31), 0.5 µL KCl solution, 2.0 µL folding buffer (5 ×, see Note 32) and 4.5 µL water and 
mix gently. 
2. RNA annealing/folding: Incubate the sample at 70 °C for 5 min; incubate at room 
temperature for 3 min and add 1.0 µL MgCl2 solution. Mix gently (see Note 33). Incubate the 
sample solution at 37 °C for 30 min, then, at room temperature for another 30 min. Low-speed 
centrifuge the sample tube to recollect any condensated solvent from the lid. 
The number of double-labeled molecules immobilized in a TIRF experiment can be increased 
by applying an additional native PAGE purification step of the pre-annealed RNA sample 
carrying the biotin-DNA.  
3. Native PAGE (6%) purification: load the sample and run the gel at 4 °C and 10-20 W for 
100 min (see Note 34).  
4. Pry the gel plates with a spatula. Cut out the gel bands with co-localized fluorescence 
emission of Cy3 and Cy5 (see Note 25). Soak the gel pieces and precipitate the hybridized 
RNAs following the same protocol as in 3.6. 
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5. The precipitated sample is re-annealed under the same condition as described in 3.10, 
giving 10 µL of the sample solution diluted with the folding buffer containing the desired Mg(II) 
concentration for the smFRET measurements (see Note 35). 
4. Notes 
1. The synthesis of compounds 1, 2, 3, and 4 for the RG (see Fig. 1) was described previously 
[13]. Complementary notes are listed here: (i) Reaction between compound 1 and dry 
methanol should be strictly controlled in a water-free environment. The incubation should last 
no longer than 15 min. Both the presence of water and longer incubation times can lead to 
byproducts. To this end, we recommend carrying out this reaction with the subsequent 
methanol evaporation on a rotary evaporator. (ii) To completely remove the methanol, we 
recommend adding 5 mL of dry CH2Cl2 (distilled over CaH2) to the residue and to co-evaporate 
both, methanol and CH2Cl2. Repeating the purification step twice yields the pale-yellow oil of 
compound 2. (iii) Compound 2 is very sensitive under ambient condition. Use it immediately 
for the next reaction step or store it at -20 °C after drying under high vacuum. However, long-
time storage is not recommended. (iv) In general, all compounds should be stored at -20 oC to 
avoid degradation. We particularly recommend drying the RG precursor under high vacuum 
and in an ice/H2O bath to remove water as much as possible. The freshly synthesized RG 
precursor is usually a viscous oil. Upon storage at -20 °C for months, crystals or solids can 
form. 
2. As the reaction proceeds, crystals or precipitates can be observed at the bottom of the tube. 
3. Activated RG easily degrades at room temperature and therefore should always be kept on 
ice. 
4. Design criterions for the guide-DNA of the dRS (Fig. 1b): (i) A phosphorylated terminal end 
of the guide-DNA is required for the addition reaction of ethylene diamine. (ii) The guide DNA 
has to bind to the RNA in such a way that the modified terminal base-pair (position n, see Fig. 
1b) locates one or two ribonucleotides up- or downstream (depending on the 5' or 3' 
modification of the guide-DNA with the RG) of the labeling site (position n + 2, see Fig. 1b). 
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(iii) Adenine and cytosine shall not be placedat the phosphorylated terminal end of the guide-
DNA to prevent its self-modification. (iv) The size of the guide-DNA should not exeed10 nt to 
allow a rational design of the dHS but should have a GC content greater than 50% to ensure 
specific and tight binding to the RNA strand. 
5. Before use, heat the CTAB solution at 60 °C for 30 min or until the solid is completely 
dissolved. 
6. Store at 4 °C. Solutions should be prepared freshly before use. 
7. A bright yellow solution should be observed after the three chemicals are mixed. If the 
solution is only light yellow or colorless, discard it, validate the used chemicals and repeat the 
reaction by mixing again the three chemicals. 
8. To prevent degradation of dRS, Solution III is recommended to be prepared immediately 
before use and should always be kept on ice. 
9. dHSs are particularly helpful for labeling ribonucleotides which are base-paired and/or 
shielded by secondary and/or tertiary structural elements. Rationally designed dHSs that bind 
up- or downstream of the RNA sequence complementary to the dRS can enhance the 
hybridization of the dRS to the RNA at moderate temperatures and thus increase the overall 
labeling efficiency. An additional benefit is that hybridization can be performed at moderate 
temperature, with reduces degradation of the RG.  
Design of the dHSs mainly considers factors such as the RNA fold, the GC content, and the 
predicted melting temperature of the respective dHS/RNA hybrid. If the RNA fold is unknown, 
secondary structure predictions should be consulted for dHS and dRS design. Herein, we 
show two examples in the context of the btuB riboswitch in which implementation of suitable 
dHS sequences has a pronounced effect. For the modification of A35 (Fig. 2), two helper 
sequences are designed to mask short segments on both sides of the target nucleotide in 
order to open up the stem loop temporarily to allow dRS hybridization. In the absence of any 
dHS only 60% of the dRS binds to the RNA at room temperature. In contrast, prior incubation 
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with one equivalent of each dHSs increases the binding efficiency of the dRS to over 95% at 
ambient temperature. By comparison, temperature induced unfolding in absence of any dHS 
shows only about 70% hybridization efficiency. For A213 (Fig. 2) the effect is even more drastic. 
Only about 20% of the dRS anneal to the RNA in the absence of dHS at room temperature, 
whereas the addition of one equivalent of each dHS leads to ~75% bound dRS. Again, thermal 
melting without dHS produces no more than 50% hybridized strands. 
10. We validated that 90 min is the optimal incubation time with sodium periodate to convert 
the reactive group to an aldehyde [13, 14]. Longer times would result in over-oxidation of the 
reactive group to an inactive ketone. At the same time sodium periodate oxidizes the 3'-
terminal ribose unit of the RNA to a di-aldehyde moiety required for biorthogonal labelling. 
Again, we validated that 90 min of incubation is sufficient for this reaction. 
11. Ethylene glycol is used as a reducing agent to quench sodium periodate. Overnight 
incubation is acceptable. A longer incubation time may induce RNA degradation.  
12. If the volume of the eluted sample does not exceed 100 µL, the lyophilization step can be 
omitted. 
13. This step is to purify the functionalized RNA from dRS, dHSs and their derivatives and 
potentially degraded RNA fragments with denaturing PAGE. The percentage of acrylamide 
varies depending on the molecular weight differences between the RNA and the DNA 
oligonucleotides. Roughly, we recommend using a low percentage of e.g. 5%, because of the 
increased RNA-soaking efficiency. Importantly, it is essential to remove the DNA 
oligonucleotides before proceeding to the subsequent steps. Without PAGE purification, we 
observed a dramatic degradation of the RNA after the subsequent dye-coupling reactions. We 
speculate binding of dRS, dHSs and/or their derivatives to the RNA may result in RNA 
conformations that are prone for degradation under the conditions of the dye-coupling 
reactions. 
14. Load the sample into multiple gel wells as needed, since the total volume including FLB is 
usually larger than the volume of a single well. 
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15. Load the non-modified RNA construct as a reference. Ensure that the loaded RNA 
concentration allows for the visualization via UV shadowing. 
16. Avoid touching the gel pieces with the tip of the pipette. Otherwise, unintendedly collected 
gel pieces/substances will co-precipitate with the RNA upon ethanol precipitation. 
17. We recommend measuring the fluorescence emission profile of Solution VI before 
proceeding to the subsequent dye-coupling steps. An emission peak around 415 nm upon 
excitation at 275 nm (or 308 nm) is indicative for a successful internal RNA modification (Fig. 
3). 
18. Be attentive not to blow the sample out of the tube. We recommend adjusting the argon 
flow rate with a blank test sample in a 1.5 mL tube containing water or TEAA buffer of the 
same volume as the sample. 
19. Because the 3'-dialdehyde is generally more reactive than the alkyne, we recommend 
performing the 3'-terminal dye-coupling prior to the internal dye-coupling. As we observed that 
Cy3 is prone to photo-bleaching and has a reduced re-orientation probability when attached 
to internal sites of the RNA, we used Cy3 for the 3’-terminal end. In addition, we recommend 
using sulfonated carbocyanine dyes due to their increased water-solubility and reduced 
interaction with the RNA-backbone owing to their negative charge [21]. 
20. Ethanol washing can be repeated until the supernatant becomes nearly colorless. 
21. Compared to Cy3, Cy5 is less likely to photo-bleach when labeled at internal sites of RNAs. 
22. Ascorbic acid solution must be prepared freshly before use as it is easily oxidized if 
exposed to air. 
23. A NAP-5 desalting column removes free dyes efficiently and is fast compared to multiple 
rounds of ethanol precipitation. 
24. For "biophysical" measurements, the denaturing PAGE purification step is mandatory, as 
it completely removes trace amounts of free dyes. Be sure the sample was purified by 
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ethanol precipitation and NAP desalting column to remove most excess of dyes before 
loading to the PAGE gel. 
25. We used a Typhoon scanner with fluorescence imaging capabilities to locate the target 
bands. The fluorescence detection is much more sensitive than UV shadowing. 
26. We estimate that about 5% of the total RNA after PAGE purification is dual-color-labeled 
based on UV-vis absorption spectra [12]. This amount is sufficient for single-molecule 
fluorescence spectroscopy. We used higher percentage PAGE to get denser bands enabling 
UV shadowing for lower concentrated RNA samples (Fig. 4). 
27. Reverse transcription stop assay is employed to probe the internal fluorophore-labeling 
sites, in which a primer anneals downstream of the putative labeling site and is extended by 
a reverse transcriptase (Fig. 5). In our experiments, reverse transcriptase exhibits varied 
susceptibility to be stalled by the fluorophore-labeled ribonucleotides depending on the 
different positions. We describe the optimized protocols of AMV reverse transcriptase that is 
best for the base-paired labeling site (A213) and SuperScript III reverse transcriptase that is 
best for the labeling site (A35) within an internal loop. 
28. In order not to waste the precious dual-color labeled RNA (Solution VIII), the single 
internally labeled sample was used skipping the 3’-terminal coupling step.  
29. Importantly, the 32P-marked primer should be shorter than 20 nucleotides and should be 
designed in such a way that it binds with its 3'-terminus less than 10 nucleotides-
downstream of the putative labeling site of the RNA (Fig. 5). In this way, we were able to 
separate the differently extended 32P-marked primers at a 1-nucleotide resolution on a high 
percentage (18%) denaturing PAGE. 
30. Be aware that the reverse transcriptase is not stalled at the presumed labeling site but 
inserts one additional nucleotide before stopping and releasing the 32P-marked primer (Fig. 
5). This effect is known as delayed chain termination (CT) [22]. 
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31. The biotin-carrying DNA oligonucleotide is used to immobilize the RNA molecule on the 
quartz surface via biotin-streptavidin interaction. The oligonucleotide is designed to bind to 
the 5'-elongated region of the RNA and not to interfere with the RNA’s native fold [19]. We 
recommend adding a two-fold excess of biotin-DNA primer to ensure that all dual-color 
labeled RNAs (~5%, see Note 26) are hybridized. The non-hybridized biotin-labeled will be 
removed by the subsequent Native PAGE purification which also removes the degraded 
RNAs and other impurities (see Note 34).  
32. The precise composition of the folding buffer depends on the folding conditions of the 
particular RNA studied. 
33. Addition of Mg(II) is required for formation of the tertiary structure. 
34. The Native PAGE purification is not mandatory. However, we recommend its application 
as otherwise the excess of biotin-labeled primers that is not hybridized to the RNA would 
block the Streptavidin binding sites (see Fig. 6), reducing the number of immobilized RNA 
molecules. 
35. Empirically, we started with the 105-fold dilution (100 pM) of the re-annealed double-
labeled RNA sample for single-molecule TIRF imaging. Adjustments may be necessary 
depending on the RNA concentration recovered from the Native PAGE purification and the 
labeling efficiency. 
Application notes: 
1. Site-specific biorthogonal fluorescent labeling of RNA is of particular interest for FRET 
studies, as this method demands labeling with two fluorophores. Further details on single 
molecule FRET or FRET gels can be found elsewhere [12, 23, 24]. 
2. The labeling scheme is not limited to fluorescent entities, but can be adapted to any 
reporter molecule such as spin labels for EPR studies [25-27]. 
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Fig. 1 (a) Synthesis scheme of the reactive group (RG) and the reactive strand (dRS). 
Details of the synthesis of compound 1, 2, 3, and 4 were described previously [14] (b) 
Scheme of the dRS binding to the RNA, showing the relative position of the labeling site to 
the guide-DNA. Adapted from [12]. 
  
22 
Fig. 2 Scheme of the secondary structure of the btuB riboswitch (a) and the hybridization 





Fig. 3 Normalized fluorescence emission profiles (background subtracted) of the 1,N6-
ethenoadenines at positions A35 (black) and A213 (red) of Solution VI upon excitation at 





Fig. 4 Probing the double-labelling by a comparative UV shadowing and fluorescence 
imaging gel. Example denaturing PAGE (10% w/v, 7 M urea) of the dual-color labeled btuB 
riboswitch with the Cy3 at the 3’-terminal end and the Cy5 at position A35. Bands on the gel 
are visualized with both, UV-shadowing (λex = 254 nm, top) and fluorescence imaging 
(excitation at 635 nm or 532 nm, respectively, bottom). Color-coded channels show Cy3 
(green) and Cy5 (red) emission. Co-localized dyes appear as yellow bands in the 
superimposed image of both channels. Control lane with the non-modified btuB riboswitch in 
the presence of both free dyes shows no fluorescence signal. Thus, intercalation of the non-
covalently added dyes Cy3 and Cy5 can be excluded. Reproduced and adapted from Figure 




Fig. 5 Probing the internal labeling of A213 (a) and A35 (b) by reverse transcription. The 
autoradiograph of the denaturing PAGE footprinting gel (18% w/v, 7 M urea) shows the 
original 32P-labeled primers (lane 1), the extended 32P-labeled primers in presence of the 
non-labeled btuB riboswitch (lane 2), and the internally labeled btuB riboswitch (lane 3). 
Short DNA oligonucleotides, 32P-labeled primer1 + 7 nt (Ref oligo1, a) and 32P-labeled 
primer2 + 3 nt (Ref oligo1, b) are shown as references (lane 4). Delayed chain termination 
(CT) is observed which reflects the insertion of one additional nucleotide past the 
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modification site [22]. Reproduced and adapted from Figure 2 in [12], by permission of 
Oxford University Press.  
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Fig. 6 Schematic depiction of the surface-immobilized dual-color labeled btuB riboswitch, 
with the Cy3 fluorophore at the 3’-end and the Cy5 fluorophore at position A213, located in a 
double-stranded region of the functional riboswitch. Reproduced and adapted from Figure 13 
in [12], by permission of Oxford University Press. 
